Cancer Clinical Trial
Official title:
Epidemiology of Venous Thromboembolism: Analyses and Publications From the DVT FREE Database
More than 5 years ago the DVT FREE Registry was conceived. Its database consists of 5,451 ultrasound-confirmed DVT patients from 183 institutions. This database is rich in information of critical importance to health care providers. The information contained within the database will be revisited to provide more detailed analyses which will be used for risk factor assessment and for decision-making regarding the implementation of VTE Prophylaxis.
BACKGROUND:
The Venous Thromboembolism (VTE) Research Group has explored and studied the epidemiology of
DVT and pulmonary embolism (PE) for more than 2 decades. The earliest analyses were done
with the database from the Framingham Heart Study. Subsequent analyses were undertaken using
the Nurses' Health Study.
More than 5 years ago the DVT FREE Registry was conceived. The concept was to accrue broad
representation of patients with ultrasound-confirmed DVT throughout the US.
The Principal Investigator began initial work on this project by developing the case report
form (CRF) with Co-Investigators. After the CRF was piloted and finalized, centers were
recruited for participation. The enthusiasm in response to DVT FREE was overwhelming. The
initial investigators meetings were conducted by videoconference shortly after September 11,
2001. Accrual of patients occurred much more rapidly than projected. Within 6 months, 5,451
patients were enrolled with ultrasound-confirmed DVT at 183 participating institutions.
Dr. Samuel Z. Goldhaber chaired the Publications Committee. The Master Paper was published
in January 2004. 3 manuscripts on subgroups and 3 manuscripts on special populations were
subsequently published under Dr. Goldhaber's supervision. The subgroup papers studied upper
extremity DVT, the relationship between DVT and symptomatic DVT and PE, and predictors of
massive DVT. The special populations papers studied gender differences in receiving
prophylaxis, utilization of vena cava filters, and pregnancy.
Though the publication record is impressive in scope, much work remains to be done. The
database is rich in information of critical importance to health care providers. The
information contained within the database should be analyzed to provide more detailed
analyses which will be used for risk factor assessment and for decision-making regarding the
implementation of VTE prophylaxis.
For the current DVT FREE publication project, we will use the database to analyze findings
that will yield 8 publications in special populations: 1) medically ill hospitalized
patients, 2) cancer patients, 3) nonorthopedic general surgery patients, 4) orthopedic
surgery patients, 5) long-haul travel patients, 6) COPD Patients, 7) Renal Patients, and 8)
Elderly Patients.
PROJECT DESCRIPTION:
1. Medically Ill Hospitalized Patients:
Medically ill hospitalized patients are the most important subgroup to study. These
patients often do not receive guideline-recommended prophylaxis. We believe that
medically ill hospitalized patients are underserved.
For this DVT FREE publication, we will exclude all patients who had surgery within the
past 3 months. We will also exclude women who were pregnant or postpartum. All other
patients will be included in these analyses. They will be stratified according to age,
height, weight, body mass index (BMI), gender, and whether they received prophylaxis.
2. Cancer Patients:
Cancer patients have received increasing attention because of the relationship between
cancer and DVT. For example, the National Comprehensive Cancer Network (NCCN) organized
a special committee to write consensus guidelines for prevention and treatment of DVT
in this patient population.
For this DVT FREE publication, we will include all patients with cancer. We will also
include whether the cancer was active and whether the patient is receiving ongoing
radiation therapy or chemotherapy. These cancer patients will be stratified according
to age, height, weight, BMI, gender, and whether they received prophylaxis.
3. Nonorthopedic General Surgery Patients:
For this DVT FREE publication, we will include all nonorthopedic general surgery
patients. These patients will have undergone surgery within the 3 months prior to DVT.
We will also explore the type of surgery (excluding orthopedic surgery) and type of
anesthetic that was used. These patients will be stratified according to age, height,
weight, BMI, gender, and whether they received prophylaxis.
4. Orthopedic Surgery Patients:
For this DVT FREE publication, we will include all orthopedic surgery patients. We will
also include patients who suffered hip fracture, pelvic fracture, upper extremity
fracture, lower extremity fracture, or other fracture within 30 days prior to
enrollment. We will also include patients with major trauma to the spine, pelvis, or
upper or lower extremities. These patients will be stratified according to age, height,
weight, BMI, gender, and whether they received prophylaxis.
5. Congestive Heart Failure (CHF)
6. COPD Patients:
For this DVT FREE publication, we will include all patients with COPD. These patients
will be stratified according to age, height, weight, BMI, gender, and whether they
received prophylaxis.
7. Renal Patients:
For this DVT FREE publication, we will include all renal patients. These patients will
be stratified according to age, height, weight, BMI, gender, and whether they received
prophylaxis.
8. Elderly Patients:
For this DVT FREE publication, we will include all elderly patients. For this study we will
define elderly as 70 years of age or older. These patients will be stratified according to
age, height, weight, BMI, gender, and whether they received prophylaxis.
;
Observational Model: Cohort, Time Perspective: Retrospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05346796 -
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
|
N/A | |
Recruiting |
NCT05094804 -
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
|
Phase 1/Phase 2 | |
Completed |
NCT04867850 -
Effect of Behavioral Nudges on Serious Illness Conversation Documentation
|
N/A | |
Enrolling by invitation |
NCT04086251 -
Remote Electronic Patient Monitoring in Oncology Patients
|
N/A | |
Completed |
NCT01285037 -
A Study of LY2801653 in Advanced Cancer
|
Phase 1 | |
Completed |
NCT00680992 -
Study of Denosumab in Subjects With Giant Cell Tumor of Bone
|
Phase 2 | |
Completed |
NCT00062842 -
Study of Irinotecan on a Weekly Schedule in Children
|
Phase 1 | |
Active, not recruiting |
NCT04548063 -
Consent Forms in Cancer Research: Examining the Effect of Length on Readability
|
N/A | |
Completed |
NCT04337203 -
Shared Healthcare Actions and Reflections Electronic Systems in Survivorship
|
N/A | |
Recruiting |
NCT04349293 -
Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways
|
N/A | |
Terminated |
NCT02866851 -
Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy
|
N/A | |
Active, not recruiting |
NCT05304988 -
Development and Validation of the EFT for Adolescents With Cancer
|
||
Completed |
NCT04448041 -
CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
|
||
Completed |
NCT00340522 -
Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
|
||
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Active, not recruiting |
NCT03844048 -
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
|
Phase 3 | |
Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
Completed |
NCT03109041 -
Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source
|
Phase 1 | |
Terminated |
NCT01441115 -
ECI301 and Radiation for Advanced or Metastatic Cancer
|
Phase 1 | |
Recruiting |
NCT06206785 -
Resting Energy Expenditure in Palliative Cancer Patients
|